Related Concept Videos
Molecules and Compounds
Types of Signaling Molecules
Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion
Positive Regulator Molecules
Positive Regulator Molecules
Ions, Molecules, and Compounds
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Development of Psoriasis Assessment Tools Among Patients in the CorEvitas Psoriasis Registry.
Wolf's isotopic response of lichen planus following contact dermatitis.
Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis.
Sustained High Efficacy and Favorable Safety Over Five Years in Patients With Burdensome Psoriasis (UNCOVER-1/UNCOVER-2).
Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR.
Treatment with SDZ-ADL, an Adalimumab Biosimilar, in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis: Results of Patient-Reported Outcome Measures from Two Phase III Studies (ADMYRA and ADACCESS).
Systemic therapy for advanced cutaneous squamous cell carcinoma.
Emerging technologies for health information in dermatology: opportunities and drawbacks of web-based searches, social media, mobile applications, and direct-to-consumer genetic testing in patient care.
MoleMapper: an application for crowdsourcing mole images to advance melanoma early-detection research.
Digital imaging applications and informatics in dermatology.
Related Experiment Video
Updated: Feb 9, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Small Molecules for Psoriasis.
1Clinical Professor of Dermatology Saint Louis University Central Dermatology St Louis, Missouri.
Acitretin and tofacitinib are oral medications for psoriasis treatment. Both are effective but carry significant safety risks for patients.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Psoriasis treatment involves various therapeutic options.
- Acitretin is an established oral, non-immunosuppressive drug for psoriasis.
- Tofacitinib is an oral Janus kinase inhibitor investigated for psoriasis.
Purpose of the Study:
- To compare the efficacy and safety profiles of acitretin and tofacitinib in psoriasis management.
Main Methods:
- Review of existing literature on acitretin and tofacitinib for psoriasis.
- Analysis of clinical trial data regarding efficacy and adverse events.
Main Results:
- Both acitretin and tofacitinib demonstrate efficacy in treating psoriasis.
- Each medication presents substantial safety risks that require careful consideration.
Conclusions:
- Acitretin and tofacitinib are viable treatment options for specific psoriasis patient populations.
- Risk-benefit assessment is crucial when selecting between these oral therapies.

